These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 17504892

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
    Moradi S, Mollabashi M, Kerman SR.
    Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The effect of bariatric surgery on inflammatory markers in women with polycystic ovarian syndrome.
    Abiad F, Khalife D, Safadi B, Alami R, Awwad J, Khalifeh F, Ghazeeri G.
    Diabetes Metab Syndr; 2018 Nov; 12(6):999-1005. PubMed ID: 30168430
    [Abstract] [Full Text] [Related]

  • 25. Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility.
    Tsai YH, Wang TW, Wei HJ, Hsu CY, Ho HJ, Chen WH, Young R, Liaw CM, Chao JC.
    Br J Nutr; 2013 Jun 28; 109(12):2190-8. PubMed ID: 23046530
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.
    Glintborg D, Andersen M, Hagen C, Frystyk J, Hulstrøm V, Flyvbjerg A, Hermann AP.
    Eur J Endocrinol; 2006 Aug 28; 155(2):337-45. PubMed ID: 16868149
    [Abstract] [Full Text] [Related]

  • 27. [Correlations between adipocytokines and insulin resistance in women with polycystic ovary syndrome].
    Li X, Li X, Huang HY, Ma D, Zhu MW, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2009 Oct 13; 89(37):2607-10. PubMed ID: 20137676
    [Abstract] [Full Text] [Related]

  • 28. Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease.
    Boulman N, Levy Y, Leiba R, Shachar S, Linn R, Zinder O, Blumenfeld Z.
    J Clin Endocrinol Metab; 2004 May 13; 89(5):2160-5. PubMed ID: 15126536
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Early metabolic derangements in daughters of women with polycystic ovary syndrome.
    Sir-Petermann T, Maliqueo M, Codner E, Echiburú B, Crisosto N, Pérez V, Pérez-Bravo F, Cassorla F.
    J Clin Endocrinol Metab; 2007 Dec 13; 92(12):4637-42. PubMed ID: 17848407
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance.
    Bahceci M, Tuzcu A, Canoruc N, Tuzun Y, Kidir V, Aslan C.
    Horm Res; 2004 Dec 13; 62(6):283-7. PubMed ID: 15542929
    [Abstract] [Full Text] [Related]

  • 35. 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
    Jakubowicz DJ, Nestler JE.
    J Clin Endocrinol Metab; 1997 Feb 13; 82(2):556-60. PubMed ID: 9024253
    [Abstract] [Full Text] [Related]

  • 36. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
    Verit FF.
    Arch Gynecol Obstet; 2010 Jun 13; 281(6):1009-14. PubMed ID: 19771438
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.
    Teede H, Ng S, Hedger M, Moran L.
    Metabolism; 2013 Oct 13; 62(10):1394-400. PubMed ID: 23768911
    [Abstract] [Full Text] [Related]

  • 39. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G, Steinberg HO, Shepard MK, Hook G, Baron AD.
    J Clin Endocrinol Metab; 2003 Feb 13; 88(2):576-80. PubMed ID: 12574183
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.